Eledon Pharmaceuticals
ELDN
ELDN
19 hedge funds and large institutions have $16.1M invested in Eledon Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
-15
Holders Change %
-44.12%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
6
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
O
1
OrbiMed
New York
|
$14.8M |
2 |
LSC
2
Lyon Street Capital
Sausalito,
California
|
$238K |
3 |
ECM
3
Element Capital Management
New York
|
$145K |
4 |
4
Renaissance Technologies
New York
|
$367K |
5 |
5
Goldman Sachs
New York
|
$76K |
Top Sellers
1 |
1
BlackRock
New York
|
$95K |
2 |
2
State Street
Boston,
Massachusetts
|
$0 |
3 |
![]()
3
JPMorgan Chase & Co
New York
|
$0 |
4 |
4
Northern Trust
Chicago,
Illinois
|
$0 |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$0 |